Selpercatinib is a medication being studied for its effectiveness in treating advanced or metastatic non-small cell lung cancer (NSCLC) that has a specific genetic change known as RET fusion. It works by targeting and blocking the activity of proteins that help cancer cells grow.

Carboplatin is a chemotherapy drug used to treat various types of cancer, including lung cancer. It works by damaging the DNA of cancer cells, which prevents them from dividing and growing.

Cisplatin is another chemotherapy medication similar to carboplatin. It is used to treat different cancers by interfering with the DNA in cancer cells, stopping them from multiplying.

Pemetrexed is a chemotherapy drug that is often used in combination with other medications to treat lung cancer. It works by blocking the cancer cells’ ability to use folate, a vitamin that is necessary for their growth.

Pembrolizumab is an immunotherapy drug that helps the immune system recognize and attack cancer cells. It is used to treat various types of cancer, including lung cancer, by blocking a protein that prevents the immune system from attacking cancer cells.

Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer – This is a type of lung cancer characterized by the presence of a specific genetic alteration known as RET fusion. It is classified as non-small cell lung cancer, which is the most common type of lung cancer. The disease is considered advanced or metastatic when it has spread beyond the lungs to other parts of the body. RET fusion-positive indicates that the cancer cells have a rearrangement in the RET gene, which can drive cancer growth. This genetic change can make the cancer more aggressive and influence how it progresses. The progression of this disease can vary, but it often involves the growth and spread of cancerous cells to distant organs.